These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 664137)

  • 1. Blood coagulation studies in patients with advanced carcinoma of the prostate treated with 2,6-cis-diphenylhexamethylcyclotetrasiloxane or estramustine-17-phosphate.
    Blombäck M; Edsmyr F; Kockum C; Paul C
    Urol Res; 1978; 6(2):95-102. PubMed ID: 664137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experimental randomized study of 2.6-cis-diphenylhexamethylcyclotetrasiloxane and estramustine-17-phosphate in the treatment of prostatic carcinoma.
    Edsmyr F; Esposti PL; Johansson B; Strindberg B
    J Urol; 1978 Dec; 120(6):705-7. PubMed ID: 731810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisobitan in treatment of prostatic cancer. A prospective controlled multicentre study.
    Alfthan O; Andersson L; Esposti PL; Fosså SD; Gammelgaard PA; Gjöres JE; Isacson S; Rasmussen F; Ruutu M; von Schreeb T; Setterberg G; Strandell P; Strindberg B
    Scand J Urol Nephrol; 1983; 17(1):37-43. PubMed ID: 6346476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic carcinoma treated with 2,6-cis-diphenylhexamethylcyclotetrasiloxane (Cisobitan).
    Krarup T; Rasmussen F; Gammelgaard PA
    Scand J Urol Nephrol; 1978; 12(1):11-5. PubMed ID: 345431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 6. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F; Esposti PL; Andersson L
    Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of treatment with estrogens and estramustine phosphate on platelet aggregation and plasma lipoproteins in non-disseminated prostatic carcinoma.
    Agardh CD; Nilsson-Ehle P; Lundgren R; Gustafson A
    J Urol; 1984 Nov; 132(5):1021-4. PubMed ID: 6492270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.
    Könyves I
    Int Urol Nephrol; 1989; 21(4):393-7. PubMed ID: 2693392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC
    Wis Med J; 1976 Sep; 75(9):S89-90. PubMed ID: 969557
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of estramustine phosphate on plasma testosterone during treatment of carcinoma of prostate.
    Kjaer TB; Nilsson T; Madsen PO
    Urology; 1975 Jun; 5(6):802-4. PubMed ID: 1136096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD; O'Donoghue EP; Kennedy CL
    Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of estramustine phosphate on prostatic cancer estimated by transrectal ultrasonotomography.
    Watanabe H; Ohe H; Ando K; Sawamura Y; Niijima T; Nakamura S; Orikasa S; Tanahashi Y; Imamura K; Yoshida H
    Prostate; 1981; 2(2):155-61. PubMed ID: 7301654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt).
    Jönsson G; Högberg B; Nilsson T
    Scand J Urol Nephrol; 1977; 11(3):231-8. PubMed ID: 339329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
    Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of prior hormonal therapy to subsequent estramustine phosphate treatment in advanced prostatic cancer.
    Slack NH; Wajsman Z; Mittelman A; Bruno S; Murphy GP
    Urology; 1979 Dec; 14(6):549-54. PubMed ID: 390810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in white cell count during treatment of advanced cancer of the prostate with estramustine phosphate and with stilboestrol.
    Daponte D; Sylvester R; De Pauw M; Fryszman A; Smith RM; Smith PH
    Br J Urol; 1983 Aug; 55(4):408-12. PubMed ID: 6349745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced carcinoma of the prostate with Estracyt.
    Nagel R; Kölln CP
    Prog Clin Biol Res; 1976; 6():267-84. PubMed ID: 1023214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.